Abstract: A fall detection and identification system includes a tag worn by a user and a server. The tag collects acceleration data from one or more sensors embedded within the tag and transmits the data to the server. The server receives the data from the tag and performs an analysis on the data to detect and identify a fall. The analysis includes determining a change in acceleration of the user over the time window based on the acceleration data; comparing the change in acceleration of the user against one or more thresholds; and determining a status of the user based on the comparison of the change in acceleration of the user against the one or more thresholds.

Abstract: A system includes a sensor attached to an individual and detects an individual's improper body movements that increase injury risk. The system includes a safety tag with an accelerometer that measures proper acceleration. Proper acceleration along multiple directions are projected onto multiple 2-D planes, generating acceleration vectors. Phasor angles of the acceleration vectors are calculated, and if the spread in phasor angles for any one 2-D plane within a moving time window exceeds a threshold, the system determines that the individual has made an improper body movement.

Abstract: A system includes a sensor attached to an individual and detects an individual's improper body movements that increase injury risk. The system includes a safety tag with an accelerometer that measures proper acceleration. Proper acceleration along multiple directions are projected onto multiple 2-D planes, generating acceleration vectors. Phasor angles of the acceleration vectors are calculated, and if the spread in phasor angles for any one 2-D plane within a moving time window exceeds a threshold, the system determines that the individual has made an improper body movement.

Abstract: A fall detection and identification system includes a tag worn by a user and a server. The tag collects acceleration data from one or more sensors embedded within the tag and transmits the data to the server. The server receives the data from the tag and performs an analysis on the data to detect and identify a fall. The analysis includes determining a change in acceleration of the user over the time window based on the acceleration data; comparing the change in acceleration of the user against one or more thresholds; and determining a status of the user based on the comparison of the change in acceleration of the user against the one or more thresholds.

Abstract: Compositions and methods are provided for modifying diagnosing and treating inflammatory disease. The methods and compositions can be used to ameliorate the effects of a deficiency in the LAP pathway for clearing dead cells. Thus, methods are further provided for modulating dead cell clearance using an effective amount of a pharmaceutical composition that targets the LAP pathway. Accordingly, pharmaceutical compositions that target the LAP pathway re provided herein. The methods and compositions described herein can be used to treat inflammatory disease, such as systemic lupus erythematosus (SLE).

Abstract: The present invention addresses the simultaneous detection and quantitative measurement of multiple biomolecules, e.g., pathogen biomarkers through either a sandwich assay approach or a lipid insertion approach. The invention can further employ a multichannel, structure with multi-sensor elements per channel.

Abstract: The present invention addresses the simultaneous detection and quantitative measurement of multiple biomolecules, e.g., pathogen biomarkers through either a sandwich assay approach or a lipid insertion approach. The invention can further employ a multichannel, structure with multi-sensor elements per channel.

Abstract: The present invention addresses the simultaneous detection and quantitative measurement of multiple biomolecules, e.g., pathogen biomarkers through either a sandwich assay approach or a lipid insertion approach. The invention can further employ a multichannel, structure with multi-sensor elements per channel.

Abstract: The present invention addresses the simultaneous detection and quantitative measurement of multiple biomolecules, e.g., pathogen biomarkers through either a sandwich assay approach or a lipid insertion approach. The invention can further employ a multichannel, structure with multi-sensor elements per channel.

Abstract: An assay element is described including recognition ligands bound to a film on a single mode planar optical waveguide, the film from the group of a membrane, a polymerized bilayer membrane, and a self-assembled monolayer containing polyethylene glycol or polypropylene glycol groups therein and an assay process for detecting the presence of a biological target is described including injecting a biological target-containing sample into a sensor cell including the assay element, with the recognition ligands adapted for binding to selected biological targets, maintaining the sample within the sensor cell for time sufficient for binding to occur between selected biological targets within the sample and the recognition ligands, injecting a solution including a reporter ligand into the sensor cell; and, interrogating the sample within the sensor cell with excitation light from the waveguide, the excitation light provided by an evanescent field of the single mode penetrating into the biological target-containing samp

Abstract: An assay element is described including recognition ligands adapted for binding to carcinoembryonic antigen (CEA) bound to a film on a single mode planar optical waveguide, the film from the group of a membrane, a polymerized bilayer membrane, and a self-assembled monolayer containing polyethylene glycol or polypropylene glycol groups therein and an assay process for detecting the presence of CEA is described including injecting a possible CEA-containing sample into a sensor cell including the assay element, maintaining the sample within the sensor cell for time sufficient for binding to occur between CEA present within the sample and the recognition ligands, injecting a solution including a reporter ligand into the sensor cell; and, interrogating the sample within the sensor cell with excitation light from the waveguide, the excitation light provided by an evanescent field of the single mode penetrating into the biological target-containing sample to a distance of less than about 200 nanometers from the wave